However, in some situations it can be challenging to differentiate between a GOC and an intraosseous mucoepidermoid carcinoma and molecular testing for a MAML2 gene rearrangement may be useful in these circumstances [27]. This evidence concerns the gene MAML2 and mucoepidermoid carcinoma.